Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
Learn the causes, risks, and what to do if you suspect sepsis.
At the 2024 UCSF-UCLA PSMA Conference, Wolfgang Fendler discusses the relevance of different PSMA PET agents in clinical practice, emphasizing that while there are various…
Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” |…
Sandoz is no longer cooperating with a U.K. industry trade group following a dispute over allegations that the company inappropriately marketed a biosimilar medicine.
Alicia Morgans discusses a study with Stacy Loeb, exploring the impact of a plant-based diet on prostate cancer survivors, based on Loeb’s paper published in…
Today’s briefing includes news on bird flu, AI in health care, a controversial dental device, Medicaid waivers, child sleep, and more.
Japan’s Shionogi & Co said on Monday its pill-based treatment for COVID-19 did not meet the primary endpoint of showing a statistically significant reduction of…
As Director of Community Outreach at the Lourie Center, Solano-Umana serves as the liaison between the H42 study and the Lourie Center’s home visiting program.…
Using human cells in laboratory rats, Michigan Medicine researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of…
Alicia Morgans interviews Toni Choueiri about the results of the KEYNOTE-564 trial, marking a significant milestone in kidney cancer treatment with pembrolizumab showing an overall…